Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025 NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), a leading artificial intelligence (AI)-driven drug development company, is pleased to announce its participation in Biotech...

Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024 NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the BIO International Convention...